SIZE-BASED ANALYSIS OF FETAL DNA FRACTION IN MATERNAL PLASMA
    1.
    发明申请
    SIZE-BASED ANALYSIS OF FETAL DNA FRACTION IN MATERNAL PLASMA 审中-公开
    母婴血浆中胎儿DNA分数的基于尺度的分析

    公开(公告)号:WO2013132305A8

    公开(公告)日:2013-11-21

    申请号:PCT/IB2013000312

    申请日:2013-03-08

    Abstract: A fractional concentration of clinically-relevant DNA in a mixture of DNA from a biological sample is determined based on amounts of DNA fragments at multiple sizes. For example, the fractional concentration of fetal DNA in maternal plasma or tumor DNA in a patient's plasma can be determined. The size of DNA fragments in a sample is shown to be correlated with a proportion of fetal DNA and a proportion of tumor DNA, respectively. Calibration data points (e.g., as a calibration function) indicate a correspondence between values of a size parameter and the fractional concentration of the clinically-relevant DNA. For a given sample, a first value of a size parameter can be determined from the sizes of DNA fragments in a sample. A comparison of the first value to the calibration data points can provide the estimate of the fractional concentration of the clinically-relevant DNA.

    Abstract translation: 基于多种大小的DNA片段的量确定来自生物样品的DNA的混合物中的临床相关DNA的分数浓度。 例如,可以确定患者血浆中母体血浆或肿瘤DNA中胎儿DNA的分数浓度。 显示样品中DNA片段的大小分别与胎儿DNA的比例和肿瘤DNA的比例相关。 校准数据点(例如,作为校准函数)指示尺寸参数的值与临床相关DNA的分数浓度之间的对应关系。 对于给定的样品,尺寸参数的第一个值可以根据样品中DNA片段的大小确定。 第一个值与校准数据点的比较可以提供临床相关DNA分数浓度的估计值。

Patent Agency Ranking